EMA warns of short­ages of two Boehringer heart drugs due to a spike in de­mand

The EMA is putting EU mem­ber states on alert over the short­age of two drugs that counter heart at­tacks due to an uptick in de­mand.

On Fri­day, the EMA sent out a warn­ing that two Boehringer In­gel­heim drugs are ex­pe­ri­enc­ing a short­age: Ac­til­yse and Metal­yse. The drugs are used as emer­gency treat­ments for adults ex­pe­ri­enc­ing acute my­ocar­dial in­farc­tion, or a heart at­tack, by dis­solv­ing blood clots that have formed in the blood ves­sels.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.